Related Experiment Video
Updated: Aug 5, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL
A Kelekar1, B S Chang, J E Harlan
1Gwen Knapp Center for Lupus and Immunology Research, Howard Hughes Medical Institute, The University of Chicago, Illinois 60637, USA.
Abstract:
The Bcl-2 related protein Bad is a promoter of apoptosis and has been shown to dimerize with the anti-apoptotic proteins Bcl-2 and Bcl-XL. Overexpression of Bad in murine FL5.12 cells demonstrated that the protein not only could abrogate the protective capacity of coexpressed Bcl-XL but could accelerate the apoptotic response to a death signal when it was expressed in the absence of exogenous Bcl-XL. Using deletion analysis, we have identified the minimal domain in the murine Bad protein that can dimerize with Bcl-xL. A 26-amino-acid peptide within this domain, which showed significant homology to the alpha-helical BH3 domains of related apoptotic proteins like Bak and Bax, was found to be necessary and sufficient to bind Bcl-xL. To determine the role of dimerization in regulating the death-promoting activity of Bad and the death-inhibiting activity of Bcl-xL, mutations within the hydrophobic BH3-binding pocket in Bcl-xL that eliminated the ability of Bcl-xL to form a heterodimer with Bad were tested for the ability to promote cell survival in the presence of Bad. Several of these mutants retained the ability to impart protection against cell death regardless of the level of coexpressed Bad protein. These results suggest that BH3-containing proteins like Bad promote cell death by binding to antiapoptotic members of the Bcl-2 family and thus inhibiting their survival promoting functions.
Insights
The pro-apoptotic protein Bad binds to anti-apoptotic Bcl-xL, inhibiting its survival function. This interaction, mediated by Bad's BH3 domain, promotes cell death, highlighting a key mechanism in apoptosis regulation.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- The Bcl-2 protein family regulates apoptosis.
- Bad is a pro-apoptotic member that dimerizes with anti-apoptotic proteins like Bcl-xL.
- Overexpression of Bad can overcome Bcl-xL's protective effects.
Purpose of the Study:
- Identify the minimal domain in Bad for Bcl-xL dimerization.
- Determine the role of dimerization in Bad's pro-apoptotic and Bcl-xL's anti-apoptotic functions.
- Investigate the mechanism by which Bad promotes cell death.
Main Methods:
- Deletion analysis to map the Bad-Bcl-xL interaction domain.
- Site-directed mutagenesis of Bcl-xL's BH3-binding pocket.
- Co-expression of Bad and Bcl-xL mutants in murine FL5.12 cells.
- Assessment of cell survival and apoptosis in response to death signals.
Main Results:
- A 26-amino-acid peptide in Bad, homologous to BH3 domains, is necessary and sufficient for Bcl-xL binding.
- Mutations in Bcl-xL's BH3-binding pocket that disrupt Bad dimerization did not always abolish Bcl-xL's survival function.
- Some Bcl-xL mutants retained protective capacity even with coexpressed Bad.
Conclusions:
- BH3-containing proteins like Bad promote apoptosis by binding to and inhibiting anti-apoptotic Bcl-2 family members.
- Dimerization is crucial for Bad to counteract Bcl-xL's survival function.
- The BH3 domain of Bad is critical for its interaction with Bcl-xL and its role in apoptosis.
Related Concept Videos
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to form...
Intralumenal Vesicles and Multivesicular Bodies
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The Intrinsic Apoptotic Pathway
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
The JAK-STAT Signaling Pathway

